AstraZeneca India announced its partnership with Alveofit, a SaaS-IoT enabled respiratory healthcare platform, to offer IoT enabled handheld spirometers at hospitals across the country.
This partnership under the aegis of A.Catalyst network aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
Dr Anil Kukreja, VP - medical affairs & regulatory, AstraZeneca India, said,
